BioSpace News Archive

Lonca demonstrated an overall response rate of 48.3% and complete response rate of 24.1% in the pivotal Phase 2 single-agent trial

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, announced the pricing of its initial public offering of 13,500,000 American Depositary Shares, each representing one Class A ordinary share, at a price to the public of US$16.50 per ADS.

99.5% reduction in annualized rate of vaso-occlusive crises (VOC) and acute chest syndrome (ACS) in Group C patients with a history of VOCs and ACS (n=14) who had at least six months follow-up

89% of evaluable patients (17/19) with transfusion-dependent β-thalassemia who do not have a β0/β0 genotype achieved transfusion independence with 11.9 g/dL median weighted average total hemoglobin (Hb) level in HGB-207

Editas Medicine, Inc., a leading genome editing company, announced results from a pre-clinical, proof-of-concept study of EDIT-301.

Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, announced the oral presentation of updated data from its French Phase 1b/2 clinical trial at the 25th European Hematology Association Annual Meeting.

Oral BTK inhibitor reaches primary endpoint in 50 percent of patients treated > 12 weeks; demonstrates fast onset and durable responses

Centene Corporation announced on June 12, 2020 its updated 2020 financial guidance. Total revenues are expected to be $109.5 billion to $111.9 billion, and diluted earnings per share are expected to be $3.06 to $3.20.

GlySens Incorporated announced that the company has closed on an incremental $15M financing.

Newsight Imaging, the CMOS image sensor chip maker for 3D machine vision and spectral analysis applications announced the release of its SpectraLIT™, a compact development kit suitable for testing Newsight technology and developing proof-of-concept devices for the healthcare and food & beverage industries or other liquids analysis.